Elanco: Valuation, Funding & Investors
Elanco is a global animal health company that researches, develops, manufactures, and commercializes pharmaceuticals, vaccines, parasiticides, and other health products for companion and food‑producing animals. The company supplies therapeutic products, preventive solutions, and support services to veterinarians, producers, and pet owners aimed at improving animal health, welfare, and productivity.
Leadership & Board
- Current Number of Employees
- 9,426
- Current LinkedIn Followers
- 442,922
Latest Estimated Valuation
- Total Amount Raised
- $250M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $250M
- Latest Funding Round
- Investment
Company Momentum
PositiveElanco LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Employee Trend
Elanco had 9,426 employees as of November 16, 2026. The number of employees decreased by 1 (0.01%) week-over-week.
Social Trend
Elanco had 442,922 followers as of November 16, 2026. The number of followers increased by 1,213 (0.27%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 30, 2024 | Investment | $250.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Ancora | Investment |
Similar Companies
A snapshot of private companies similar to Elanco, helping you discover and navigate related company profiles.







